STAT3 and neoplasm: Silibinin (SL), a bimodal Src homology-2 domain and DNA-binding domain-targeting inhibitor of STAT3 [22], has also shown regulation of EMT and inhibition of angiogenesis, which would be beneficial to comprehensively regulate the tumor microenvironment (TME) against metastasis.